UnitedHealth Group Incorporated (NYSE:UNH) – Equities researchers at Oppenheimer Holdings lifted their FY2017 earnings per share estimates for shares of UnitedHealth Group in a note issued to investors on Tuesday. Oppenheimer Holdings analyst M. Wiederhorn now anticipates that the healthcare conglomerate will earn $9.97 per share for the year, up from their prior forecast of $9.88. Oppenheimer Holdings currently has a “Outperform” rating and a $205.00 price target on the stock.
A number of other research analysts have also commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research note on Friday, July 21st. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BidaskClub lowered shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Finally, Barclays PLC raised their price objective on shares of UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a research note on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $215.27.
ILLEGAL ACTIVITY NOTICE: “Oppenheimer Holdings Comments on UnitedHealth Group Incorporated’s FY2017 Earnings (UNH)” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/10/29/oppenheimer-holdings-comments-on-unitedhealth-group-incorporateds-fy2017-earnings-unh.html.
Shares of UnitedHealth Group (NYSE:UNH
) opened at 203.25 on Thursday. The firm has a market cap of $201.01 billion, a PE ratio of 23.08 and a beta of 0.63. UnitedHealth Group has a 12-month low of $133.03 and a 12-month high of $207.80. The company has a 50 day moving average price of $197.17 and a 200-day moving average price of $185.63.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.17 EPS.
Several large investors have recently modified their holdings of the business. Osborn Williams & Donohoe LLC boosted its stake in shares of UnitedHealth Group by 6.1% during the 3rd quarter. Osborn Williams & Donohoe LLC now owns 14,006 shares of the healthcare conglomerate’s stock valued at $2,743,000 after buying an additional 810 shares during the period. Curbstone Financial Management Corp boosted its stake in shares of UnitedHealth Group by 74.7% during the 3rd quarter. Curbstone Financial Management Corp now owns 3,800 shares of the healthcare conglomerate’s stock valued at $744,000 after buying an additional 1,625 shares during the period. MPS Loria Financial Planners LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $1,254,000. Intl Fcstone Inc. acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at $2,324,000. Finally, RNC Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.7% during the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after buying an additional 13 shares during the period. 86.11% of the stock is owned by institutional investors.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now directly owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock valued at $14,981,909 in the last three months. Company insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.